High dose tumor necrosis factor-α and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a> 90% respones rate and limb preservation.

Author(s)

Journal

  • Cancer

    Cancer 79, 1129-1137, 1997

Cited by:  1

Codes

  • NII Article ID (NAID)
    10005811030
  • Article Type
    Journal Article
  • Data Source
    CJPref 
Page Top